Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess

Updated on: July 01,2024 0

Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess

Updated on:July 01,2024 0

How to Follow a Cirrhosis Diet

How to Follow a Cirrhosis DietWhat You Should Eat and What You Should Avoid When You Have Liver DiseaseByCharles DanielMedically reviewed byRobert Burakoff, MDA cirrhosis diet

Updated on: July 01,2024 0

How to Follow a Cirrhosis Diet

How to Follow a Cirrhosis DietWhat You Should Eat and What You Should Avoid When You Have Liver DiseaseByCharles DanielMedically reviewed byRobert Burakoff, MDA cirrhosis diet

Updated on:July 01,2024 0

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

Updated on: July 01,2024 0

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

Updated on:July 01,2024 0

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on: June 06,2024 6

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on:June 06,2024 6

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024 0

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease

Updated on: May 26,2024 8

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease

Updated on:May 26,2024 8

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi

Updated on: July 10,2024 0

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi

Updated on:July 10,2024 0

Cross-disciplinary research makes strides in hepatitis C vaccine development

byUniversity of CopenhagenE1–E2 interaction in the membrane. Credit:Nature(2024). DOI: 10.1038/s41586-024-07783-5Around 58 million people suffer from chronic inflammation caused by t

Updated on: October 04,2024 0

Cross-disciplinary research makes strides in hepatitis C vaccine development

byUniversity of CopenhagenE1–E2 interaction in the membrane. Credit:Nature(2024). DOI: 10.1038/s41586-024-07783-5Around 58 million people suffer from chronic inflammation caused by t

Updated on:October 04,2024 0

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on: July 19,2024 0

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on:July 19,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024 0

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on: September 11,2024 0

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on:September 11,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on: September 02,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on:September 02,2024 0